---
title: "Finasteride - Benign Prostatic Hyperplasia - 2"
sidebar: mydoc_sidebar
permalink: db01126-mesh-d011470-2.html
toc: false 
---


Path ID: `DB01126_MESH_D011470_2`
{% include image.html url="images/db01126-mesh-d011470-2.png" file="db01126-mesh-d011470-2.png" alt="db01126-mesh-d011470-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D018120 | Finasteride | Drug |
| UniProt:P31213 | 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Protein |
| MESH:D013196 | Dihydrotestosterone | ChemicalSubstance |
| MESH:D011470 | Benign prostatic hyperplasia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Finasteride | DECREASES ACTIVITY OF | 3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2 |
| 3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2 | INCREASES ABUNDANCE OF | Dihydrotestosterone |
| Dihydrotestosterone | POSITIVELY CORRELATED WITH | Benign Prostatic Hyperplasia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01216](https://go.drugbank.com/drugs/DB01216)
